Results of a randomised trial assessing the effectiveness of different dosages of levofloxacin to cure Helicobacter pylori infection

This dataset presents the results of a randomised clinical trial involving 400 participants, which aimed to compare the effectiveness, safety, and compliance of different dosages of levofloxacin used to cure Helicobacter pylori (H. pylori) infection. <br>Patients were assigned to either Group A or Group B, and received esomeprazole, amoxicillin, colloidal bismuth pectin and levofloxacin 500 mg once per day (group A); or levofloxacin 200 mg twice per day (group B) over a 14 day period.<br>The presence of H. pylori was assessed before and after the trial using c-urea breath testing (C-UBT). <br>The dataset is comprised of an Excel spreadsheet with a single tab. Each of the 400 patients is assigned a number, and the dataset includes their baseline C-UBT result, randomised treatment group and follow-up C-UBT; any adverse reactions noted by patients during the trial period; and whether the study was completed per the protocol analysis.